ESC 365 - PCSK9 inhibition: The new player in the field.

ESC Premium Access

PCSK9 inhibition: The new player in the field.

Session: LDL-Cholesterol lowering at a turning point

Topic: Lipids

Speaker: Professor D. Ural (Istanbul, TR)

Event: EuroPRevent Meeting 2016

Congress Presentation

Add to my library

About the speaker

Professor Dilek Ural

Koc University School of Medicine, Istanbul (Türkiye)

3 presentations

0 follower

3 more presentations in this session

2016 update on LDL as a risk factor.

Speaker: Professor L. Tokgozoglu (Ankara, TR)

Status of CVD Health and cholesterol in Europe

Speaker: Doctor S. Sans Menendez (Barcelona, ES)

The future of LDL lowering Recent data from PCSK9 inhibitors and outlook for upcoming trials.

Speaker: Professor U. Landmesser (Berlin, DE)

Access the full session

LDL-Cholesterol lowering at a turning point

Speakers: Professor D. Ural, Professor L. Tokgozoglu, Doctor S. Sans Menendez, Professor U. Landmesser

About the event

EuroPRevent Meeting 2016

14 June - 15 June 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources